United States · Platforms & data · MarketBeat
ImmuCell Q3 Earnings Call Highlights

Detailed summary
ImmuCell (NASDAQ:ICCC) reported a 46% increase in third-quarter product sales and returned to profitability as improved manufacturing output and stronger demand supported its First Defense calf-health products. The company’s unaudited product sales rose to $8 million for the quarter ended Sept. 30,
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




